Posted by Michael Wonder on 04 Oct 2017
FDA approves Botox Cosmetic (OnabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults
3 October 2017 - Botox Cosmetic is the only treatment of its kind approved by the FDA for forehead lines, crow's feet lines and glabellar lines.
Today Allergan announced the FDA approval of Botox Cosmetic for its third indication, the temporary improvement in the appearance of moderate to severe forehead lines associated with frontalis muscle activity in adults. This approval makes the brand the first and only neurotoxin indicated for three facial treatment areas - forehead lines, crow's feet lines and glabellar lines.
As the category leader, Botox Cosmetic is also the only neurotoxin brand to receive approval of aesthetic indications beyond glabellar lines in the U.S.
